US FDA announces online database to track food contaminants
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly
(Reuters) -The U.S. Food and Drug Administration on Thursday launched an online searchable database listing contaminant levels in human foods, reflecting Health Secretary Robert F. Kennedy Jr.'s ongoing efforts to reduce chemicals in food since taking office.
The FDA said if a food product has contaminants exceeding established levels, the agency may find the food to be unsafe. However, it added these levels do not represent "permissible levels of contamination".
The Health Secretary has often stressed reducing chemicals in food and, in the previous week, directed the FDA to revise safety rules to help eliminate a provision allowing companies to self-affirm food ingredient safety.
RFK Jr. also told food companies in a meeting earlier this month that the Trump administration wanted artificial dyes out of the food supply before Kennedy leaves office.
The FDA said it is establishing an online database called "Chemical Contaminants Transparency Tool" to provide a list of contaminant levels called "tolerances, action levels and guidance levels" to evaluate the potential health risks of these contaminants in human foods.
"Ideally there would be no contaminants in our food supply, but chemical contaminants may occur in food when they are present in the growing, storage or processing environments," said Acting FDA Commissioner Sara Brenner.
The online database also provides information such as the contaminant name, commodity and contaminant level type.
The FDA will continue to monitor the food supply by testing foods through several different programs, the agency said on Thursday.
(Reporting by Sneha S K in Bengaluru; Editing by Vijay Kishore)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Investing.com’s stocks of the week
- Hyperfine wins FDA clearance for updated portable MRI software
- Keenova doses first patient in Phase 3 hammer toe drug trial
Create E-mail Alert Related Categories
FDA, ReutersRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share